What Does Ncardia Do?

Total employees58
HeadquartersLeuven
Founded2011

Ncardia is a fully integrated Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) focused on induced Pluripotent Stem Cell (iPSC) technology. They specialize in the development, manufacturing, and commercialization of iPSC-derived cells (e.g., cardiomyocytes, neurons) and assays for drug discovery, toxicology, and cell therapy development. Ncardia aims to provide its partners with robust, scalable, and translatable human cellular models and services to de-risk and accelerate therapeutic programs from discovery to clinic.

Where Is Ncardia's Headquarters?

HQ Function

The Leuven headquarters serves as the central hub for Ncardia's corporate governance, strategic planning, finance, and global operational management. It likely also supports R&D and business development activities.

Notable Features:

Situated within Bio-Incubator 1, the headquarters benefits from modern laboratory and office facilities designed for life science companies, fostering collaboration and access to a rich biotech ecosystem.

Work Culture:

Ncardia's work culture is expected to be science-driven, innovative, and collaborative, emphasizing quality, precision, and teamwork to advance iPSC technology and meet client needs in a dynamic industry.

HQ Significance:

The strategic location in Leuven provides Ncardia with access to top talent, research institutions, and a network of biotech companies, enhancing its innovation capabilities and European presence.

Values Reflected in HQ: The headquarters' location and setup reflect Ncardia's commitment to scientific excellence, innovation, collaboration, and being at the forefront of stem cell technology.

Location:

Ncardia operates globally with key facilities in Europe (Belgium, Netherlands, Germany) and North America (USA). This network supports worldwide pharmaceutical and biotech companies, and academic institutions by providing iPSC-derived cell products, custom assay development, disease modeling, and GMP-ready manufacturing services for drug discovery, safety pharmacology, and cell therapy development.

Street Address:

Gaston Geenslaan 1, Bio-Incubator 1

City:

Leuven

State/Province:

Flemish Brabant

Country:

Belgium

Where Else Does Ncardia Operate Around the World?

Leiden, Netherlands

Address: Zernikedreef 12, BioPartner 5 Building, 2333 CL Leiden, The Netherlands

Serves as a key European center for iPSC production, R&D, and commercial activities, supporting clients across the continent.

Cologne, Germany

Address: Nattermannallee 1, 50829 Cologne, Germany

Contributes significantly to Ncardia's European production capacity and scientific expertise in specialized iPSC-derived cell types and services.

Sayreville, New Jersey, USA

Address: 2400 Main Street Extension, Suite 100, Sayreville, New Jersey 08872, USA

Drives Ncardia's growth and service delivery in North America, catering to pharmaceutical, biotech, and academic partners in the region.

Buying Intent Signals for Ncardia

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ncardia? Meet the Executive Team

As of April 2025, Ncardia' leadership includes:

Stefan Braam, PhD - Chief Executive Officer
Jorg Rühle - Chief Financial Officer
Andy Holt - Chief Commercial Officer
Shushma Rekhi, PhD - Chief Scientific Officer
Goran Conradson - Vice President, Head of Global Operations

Who's Investing in Ncardia?

Ncardia has been backed by several prominent investors over the years, including:

Kiniciti (a Wells Fargo company)

What Leadership Changes Has Ncardia Seen Recently?

Hire3
Exits0

Ncardia significantly strengthened its executive leadership team over the past 12 months with strategic appointments in finance, science, and commerce to drive its next phase of growth and innovation in the iPSC field. No major executive departures were publicly announced during this period.

New Appointments:

Jorg Rühle, Jorg Rühle was appointed as Ncardia's new Chief Financial Officer, bringing extensive financial leadership experience in the life sciences industry.
Shushma Rekhi, PhD, Dr. Shushma Rekhi joined Ncardia as Chief Scientific Officer to spearhead scientific strategy and innovation in iPSC technology.
Andy Holt, Andy Holt was appointed as Chief Commercial Officer to lead Ncardia's global commercial operations and market expansion efforts.

What Technology (Tech Stack) Is Used byNcardia?

Discover the tools Ncardia uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ncardia Email Formats and Examples

Ncardia commonly uses the [first].[last]@ncardia.com email format for its employees. This is a standard professional email structure in many life science and technology companies.

[first].[last]@ncardia.com

Format

john.doe@ncardia.com

Example

85%

Success rate

What's the Latest News About Ncardia?

Ncardia WebsiteApril 18, 2024

Ncardia to Showcase Latest iPSC Innovations at ISSCR 2024 Annual Meeting

Ncardia announced its participation in the International Society for Stem Cell Research (ISSCR) 2024 Annual Meeting in Hamburg. The company will present its cutting-edge advancements in iPSC technology, including new cell models and applications relevant for drug discovery and cell therapy....more

PR NewswireNovember 28, 2023

Ncardia Appoints Jorg Rühle as Chief Financial Officer

Ncardia announced the appointment of Jorg Rühle as its new Chief Financial Officer. Mr. Rühle brings over 20 years of experience in finance and strategy within the life sciences and technology sectors to support Ncardia's continued growth and strategic objectives....more

Ncardia WebsiteOctober 17, 2023

Ncardia Appoints Shushma Rekhi, PhD as Chief Scientific Officer

Ncardia strengthened its leadership team with the appointment of Shushma Rekhi, PhD, as Chief Scientific Officer. Dr. Rekhi will lead Ncardia's scientific vision, research and development programs, and innovation pipeline for iPSC-based solutions....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ncardia, are just a search away.